Lyrical Asset Management LP Invests $126.66 Million in Henry Schein, Inc. (NASDAQ:HSIC)

Lyrical Asset Management LP purchased a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 1,830,276 shares of the company’s stock, valued at approximately $126,655,000. Henry Schein accounts for approximately 1.9% of Lyrical Asset Management LP’s investment portfolio, making the stock its 26th biggest position. Lyrical Asset Management LP owned 1.47% of Henry Schein as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Versant Capital Management Inc lifted its holdings in shares of Henry Schein by 274.6% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after buying an additional 335 shares during the period. Venturi Wealth Management LLC raised its position in Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock worth $41,000 after acquiring an additional 569 shares in the last quarter. Quent Capital LLC lifted its holdings in Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after acquiring an additional 323 shares during the period. Smartleaf Asset Management LLC boosted its position in shares of Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after purchasing an additional 143 shares in the last quarter. Finally, City State Bank acquired a new position in shares of Henry Schein during the 4th quarter worth $55,000. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein Trading Down 1.7 %

Shares of HSIC stock opened at $65.47 on Friday. The company has a market capitalization of $8.13 billion, a price-to-earnings ratio of 26.94, a PEG ratio of 2.13 and a beta of 0.84. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The firm has a 50-day moving average price of $73.96 and a 200 day moving average price of $72.58. Henry Schein, Inc. has a twelve month low of $63.00 and a twelve month high of $82.49.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. During the same period in the prior year, the firm earned $0.66 EPS. The business’s quarterly revenue was up 5.8% on a year-over-year basis. Research analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts recently commented on the stock. UBS Group reduced their price objective on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, February 26th. Barrington Research reiterated an “outperform” rating and set a $90.00 price target on shares of Henry Schein in a research report on Wednesday, February 26th. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and upped their price target for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Wells Fargo & Company began coverage on Henry Schein in a report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price objective for the company. Finally, Jefferies Financial Group upped their target price on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $81.10.

Insider Transactions at Henry Schein

In other news, Director Philip A. Laskawy sold 2,604 shares of the company’s stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now owns 24,805 shares of the company’s stock, valued at $1,762,147.20. This represents a 9.50 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Bradford C. Connett sold 4,036 shares of the firm’s stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares in the company, valued at $4,460,251.20. This represents a 6.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.